Genetic Technologies (ASX:GTG) Total Assets : A$6.19 Mil (As of Jun. 2024)

View and export this data going back to 1987. Start your Free Trial

What is Genetic Technologies Total Assets?

Genetic Technologies's Total Assets for the quarter that ended in Jun. 2024 was A$6.19 Mil.

During the past 12 months, Genetic Technologies's average Total Assets Growth Rate was -26.30% per year. During the past 3 years, the average Total Assets Growth Rate was 35.60% per year. During the past 5 years, the average Total Assets Growth Rate was 48.60% per year. During the past 10 years, the average Total Assets Growth Rate was 11.60% per year.

During the past 13 years, Genetic Technologies's highest 3-Year average Total Assets Growth Rate was 100.10%. The lowest was -34.30%. And the median was -3.85%.

Total Assets is connected with ROA %. Genetic Technologies's annualized ROA % for the quarter that ended in Jun. 2024 was 0.00%. Total Assets is also linked to Revenue through Asset Turnover. Genetic Technologies's Asset Turnover for the quarter that ended in Jun. 2024 was 0.00.

Genetic Technologies Total Assets Historical Data

The historical data trend for Genetic Technologies's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genetic Technologies Total Assets Chart

Genetic Technologies Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Total Assets

Get a 7-Day Free Trial

15.63

22.97

20.80

14.86

6.19

Genetic Technologies Quarterly Data
	Jun19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Assets	Get a 7-Day Free Trial															-	8.47	-	6.19	-

Genetic Technologies Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Genetic Technologies's Total Assets for the fiscal year that ended in Jun. 2024 is calculated as

Total Assets	=	Total Equity (A: Jun. 2024 )	+	Total Liabilities (A: Jun. 2024 )
	=	1.83	+	4.356
	=	6.19

Genetic Technologies's Total Assets for the quarter that ended in Jun. 2024 is calculated as

Total Assets	=	Total Equity (Q: Jun. 2024 )	+	Total Liabilities (Q: Jun. 2024 )
	=	1.83	+	4.356
	=	6.19

Genetic Technologies (ASX:GTG) Total Assets Explanation

Total Assets is connected with ROA %.

Genetic Technologies's annualized ROA % for the quarter that ended in Jun. 2024 is

ROA %	=	Net Income (Q: Jun. 2024 )	/	( (Total Assets (Q: Mar. 2024 )	+	Total Assets (Q: Jun. 2024 ))	/ count )
	=	0	/	( (0	+	6.187)	/ 1 )
	=	0	/	6.187
	=	0.00 %

Note: The Net Income data used here is four times the quarterly (Jun. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Genetic Technologies's Asset Turnover for the quarter that ended in Jun. 2024 is

	Asset Turnover
=	Revenue (Q: Jun. 2024 )	/	( (Total Assets (Q: Mar. 2024 )	+	Total Assets (Q: Jun. 2024 ))	/ count )
=	0	/	( (0	+	6.187)	/ 1 )
=	0	/	6.187
=	0.00

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Genetic Technologies Total Assets Related Terms

Thank you for viewing the detailed overview of Genetic Technologies's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Genetic Technologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetic Technologies Ltd (ASX:GTG) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

GENE:USA 0A4N:UK DU8:Germany

Address

60-66 Hanover Street, Fitzroy, Melbourne, VIC, AUS, 3065

Website

https://www.gtglabs.com

Genetic Technologies Ltd is an Australia-based molecular diagnostics company that offers predictive testing and assessment tools to help physicians proactively manage women's health. The company has developed BREVAGenplus which is a clinically validated risk assessment test for non-hereditary breast cancer. It also provides genetic testing services including medical testing, animal testing, forensic testing, and plant testing. The company markets BREVAGenplus to healthcare professionals in breast healthcare and imaging centers, as well as to obstetricians/ gynecologists (OBGYNs) and breast cancer risk assessment specialists. The majority of the company's revenue is generated from Australia and the United States. The group has two operating segments: EasyDNA and GeneType/Corporate.

Genetic Technologies Headlines

No Headlines